• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Certain novel quinoline carboxylic acid derivatives, being the compounds of the general formula: <IMAGE> (wherein R2 is halogen; R3 is a 1- piperazinyl or 4-(C1-C5)alkyl- piperazinyl; and either R1 is (C1-C5) alkyl and R4 is halogen or (C1-C5) alkyl, or R1 and R4 are each alkylene and together form a 5 or 6 membered ring which may be substituted by a (C1-C5) alkyl radical) and the hydrates and salts thereof, possess good anti-bacterial activity against both gram-negative and gram-positive bacteria. They may be prepared by reacting a corresponding 7-halo quinoline carboxylic acid derivative with a compound of formula R3H. The 7-halo quinoline carboxylic acid derivatives employed as starting materials are novel compounds which may be prepared by processes analogous to known processes.
    公开号:SU978727A3
    申请号:SU802968349
    申请日:1980-08-21
    公开日:1982-11-30
    发明作者:Ирикура Цутому；Кога Хироси；Муралма Сатоси
    申请人:Киорин Сейяку Кабусики Кайся (Фирма)；
    IPC主号:
    专利说明:

    3978 A mixture of 3 ethoxycarbonyl-β-oxy-6, 7,8-trifluoroquinoline (3.0 g), anhydrous potassium carbonate (7.6 g, ethyl iodide (8.8 ml) and N, M-dimethylformamide (DNL) (100 ml is heated by stirring at 90-100 ° for 10 hours. The reaction mixture is evaporated to dryness, water is added, the residue is collected, washed with water and dried. The residue is dissolved in dichlrmetane, filtered and evaporated. 18% - is added to the residue. hydrochloric acid (50 ml) and ethanol (25 ml). The mixture is boiled for 2.5 hours. After cooling, the residue is filtered, washed with water and dried. The residue is recrystallized Ate from a mixture of DMF and ethanol to obtain 2.1 g of 1-ethyl-1,4-dihydro- (-oxy-6,7,8-triLorquinolin-3-carboxylic acid in the form of colorless needles, etc., 239 -2b1 ° C. Found,%: C 53.30; H 2.88; NS.2k; Calculated,%: C 53.15; H 2.97; N5.16; Starting compound — 3-ethoxycarb, nyl-oxy -6,7,8-trifluoroquinoline - prepared as follows: / J A mixture of 2,3, -trifluoroaniline (, 9 g) and ethoxymeulenenmalonic acid diethyl ester (7.2 Vg; heated at 120-1 ° C for 1 h. After cooling, simple diphenyl ether (50 ml) is added to the mixture and boiled for 30 minutes. After cooling, benzene is added to the mixture, the precipitate is filtered, washed with benzene, dried and recrystallized from DMF to obtain 5.7 g of 3-ethoxycarbonyl-α-oxy-6,7,8-trifluoroquinoline as a colorless powder, mp 280- 283 C (decomposition). Found, I: C 52.83; H 2, N 5,10. Calculated,%: C 53.15; H 2.97; N 5.16. Example 2. 1-ethyl-6,8-difluoro 1, -dihydro-oxo-7, - {1-piperazinyl) quinoline-3-carbonoic acid hydroxychloride. A mixture of 1-ethyl-1, 4-dihydro-α-oxo-6, 7.0-trifluoroquinoline-3-carboxylic acid (1.35 g), piperazine (2.2 g) and pyridine (10 ml) is boiled within 6 hours. The reaction mixture is evaporated to dryness, dilute hydrochloric acid is added to the residue and the pH is adjusted to 1, and the precipitated axis 4 is filtered. The residue is recrystallized from water and 1.45 g of 1-ethyl-6,8-difluoro-1, ighydro-4-oxo-7 (1-piperazinyl) quinoline-3-carboxylic acid hydrochloride are obtained in the form of colorless crystals, mp. 300 C. Found,%: C .51, 07; H k, 73; N 11, 18, Calculated,%: C 51.1; H, 85; 11, Example 3. 1-Ethyl-6,8-difluoro-1, -dihydro-1-oxo-7 - (- methyl-1-piperazinyl) quinoline-3-carboxylic acid. 1-Ztil-6, -8-difluoro-1, 4-dihydro-oxo-7- (1-piperazinyl) 3-carboxylic acid hydrochloride mixture (0.75 g) sodium formate (0.27 g), of formic acid (A ml) and formaldehyde solution (4 ml) is boiled for 5 hours. The reaction mixture is evaporated. Water (10 ml) is added to the residue, the pH of the solution is adjusted to 7 with 10% sodium hydroxide solution and extracted with dichloromethane. The organic layer is washed with water, dried with anhydrous sodium sulfate and evaporated. The residue is recrystallized from a mixture of DMF and ethanol, resulting in a gram of 1-ethyl-6, 8-difluoro-1 ./13- dihydro-oxo-7-t 4-methyl-1-piperazinyl} quinoline-3-carboxylic acid in the form of colorless crystals, so pl. 2A5-2A6 ° C; Found,%: C 57.97; H 5, N 12.02. C 58.11; H 5, (5; Calculated, N 11.96, Example: 8,9-Difluoro-6, 7-dihydro-5-methyl-1-OXO-1H, 5H-benzo i, i quinolizin 2-carboxylic acid., A mixture of 5,6-difluoro-2-methyl-1,2,3, -tetrahydroquinoline (5.0 g) and ethoxymethylenemalonic acid diethyl ester (5.9 g) is heated at 120-130 ° C for 5 hours. After (polyphos is added to the mixture (hydrochloric acid, tO g) and heated with stirring to 120-13 ° C for 20 minutes. After cooling, water (80 ml), concentrated hydrochloric acid (30 ml) are added to the mixture and boil for 3 hours. The reaction mixture is cooled and diluted with water. the precipitate was filtered off, washed with water, and dried. The residue perekristallizopyvayut mixture of DMF and ethanol,
    as a result, (5 g of 8,9-difluoro-6,7-dihydro-5-methyl-1-oxo-1I, 5H-benzo fi, j quinolysin-2-carboxylic acid are obtained in the form of colorless crystals, mp 287-288 ° C.
     Found,% C 60.38; H 3, N, 9.
     Calculated,% C 60.22; H 3.97; N 5.02.
    The starting compound, 5,6-difluoro-2-methyl-1, 2,3, -tetrahydroquinoline, was prepared as follows.
    Nitric acid (11.2 g) was added dropwise to the mixture of 1-bromo-3, -difluorobenzene (27 g) and concentrated sulfuric acid (30 ml) at 20-30 ° C and then stirred for 2 hours at 50-6P ° D, “The mixture is placed on ice, extracted with benzene, washed with water, dried with anhydrous sodium sulfate and evaporated, resulting in 32.7 g of 2-bromo-A, 5-difluoro-1-nitrobenzene as yellow oil dusta substance
    2-Bromo-4,5-difluoro-1-nitrobenzene (32.7 g) with stirring was added to a mixture of powdered iron (6 g), concentrated hydrochloric acid (6.8 ml) and water (500 ml) at 80 - 90 ° C. Then stirred for 2 hours at 83-90 ° C. After cooling, the mixture is basified with potassium carbonate, extracted with benzene, washed with water, dried with anhydrous sodium sulfate, and evaporated.
    The remaining oily residue is pergon- gated, resulting in a yield of 19.5 g of 2-bromo-, 5-difluoroaniline as an oily substance, t, bales. 120125 ° С (27 mm of mercury "st.)"
    Under stirring, a mixture of 2-bromo-, 5 difluoroaniline (19.5 g) and polyphosphoric acid (100 g) is added to this complex ester acetoacetate ester (13 g) and stirred for 2 h. The mixture is cooled and neutralized with 10% sodium hydroxide solution. The precipitate formed is filtered, washed with water and dried. The residue is recrystallized from DMF and 11.3 g of 8-bromo-5,6-diphthorg-oxy-2-methylquinoline are obtained in the form of colorless needle crystals, mp. 278-279 C .;
    A mixture of 8-bromo-5,6-difluoro-4-hydroxy-2-methylquinoline (11.3 g) and oxychloride. Phosphorus (100 ml) was boiled in 5 mg of anemia. Excess phosphorus oxychloride was evaporated and the residue was neutralized with an aqueous solution of potassium carbonate under ice cooling. The precipitate is extracted with dichloromethane., Washed with water, dried with anhydrous sodium sulfate and evaporated. The residue is recrystallized from ethanol and 9.3 g of 8-bromo-chloro-5,6-difluoro-2-methylquinoline are obtained in the form of colorless needle-like crystals, mp, ItOU2 ° c;
    A mixture of 8-bromo-chloro-5,6-difluoro-2-methylquinoline (9.3 g), sodium acetate (5.2 g), acetic acid (100 ml and 100 palladium on activated carbon (3.0 g) The mixture is filtered, evaporated and basified with an aqueous solution of potassium carbonate, then extracted with dichloromethane, washed with water, dried with anhydrous sodium sulfate and evaporated to give 5.3 g. -2-methylquinoline.
    A mixture of 5,6-difluoro-2-methylquinoline (5.3 g), platinum dioxide (0.3 g) and methanol (150 ml) is hydroenzymed at room temperature under pressure
    LO atm until complete absorption of hydrogen. The mixture is filtered and evaporated, whereby 5.0 g of 5,6-difluoro-1,2,3, -tetrahydro-2-methy lhinolin are obtained,
    Example 5 9-Fluoro-6, 7-dihydro-5 methyl-1-oxo (1-piperazinyl) -1H, 5H-6eH3o i, j Hinolisin-2-carboxylic acid hydrochloride.
    A mixture of 8,9-difluoro-6,7-Dihydro - $ -methyl-1-oxo-1H-5H-benzo 1, j Chinolysin-2-carboxylic acid (1, g), piperazine (2.2 g) and N - picoline (5 ml) is boiled for 7.5 hours. The mixture is evaporated
    dry and acidified with hydrochloric acid. The precipitate formed is filtered and recrystallized from a mixture of water and ethanol. As a result, 1.0 g of 9 FTor-6,7-dihydro-5-methyl-1-oxo-8 (.1-piperazinyl) -1 H, 5H-benzo
    i, j quinolizin-2-carboxylic acid in the form of colorless crystals ;, so pl. 300 ° C. . Found,%: C 52.25; H 5,
    -l ..
    . calculated,%: C 52.30; H 5.97; N 10.17. 79 6. 9 Fluorine-6,7-dihydP p and mepero-5 methyl-1-oxo-8- (-methyl-1-piperazinyl) 1H, 5H-benzo P ,, quinolizin-2-carboxylic acid. A mixture of 9-fluoro-6,7 dihydro-5 methyl-1-oxo-8- (1-piperazinyl -1H, 5H-6eH3o i, j quinolizin-2-carboxylic acid hydrochloride (0.9 g), sodium formate (0 , 6A g), 87% formic acid (5 ml) and 37% solution of rmaldehyde (5 ml) are boiled for 5 hours. The mixture is evaporated to dryness and an aqueous solution of sodium hydroxide is added, the alkaline solution is neutralized acetic acid and extracted with dichloromethane. The organic layer is washed with water, dried with anhydrous sodium sulfate, and evaporated. The solid residue is recrystallized from a mixture of DMF and ethanol and get 0.70 g:) - fto p-6, 7-dihydro-5-methyl-1-oxo-8-li-methyl-1-piperazinyl) -1H, 5H-benzo 1, Zquinolizin-2-carboxylic acid in the form of colorless needles, so pl. 2b1-2bzs. Found,%: C 63.5; H 6.20; N 11.65. V l aNjF Calculated, g: C 63.50; H 6.17; N 11.69. Example 7. 8-Chloro-1-ethyl-6, 7-Aiftor-1,1-dihydro-oxy-quinoline-3-caronic acid. A mixture of 8-chloro-6,7-Difluoro-1,4-dihydro-oxoquinoline-3-carboxylic acid ethyl ester (12.0 g) of anhydrous potassium carbonate (29 g), ethyl iodide (33.6 ml) and DMF (300 ml) is stirred at 90-100 ° C for 12 hours. To the mixture is added without aqueous potassium carbonate (I, 5 g), iodine iodine (16.8 ml) and heated, stirring at -100 ° C. for 9.5 hours. The mixture is evaporated to dryness, water is added, the mixture is extracted with dichloromethane and evaporated. Hydrochloric acid (100 ml) was added to the residue and boiled for 4 hours. Water (200 ml) was added to the aqueous solution and extracted with: dichloromethane. The dichloromethane layer is washed and evaporated. The residue is recrystallized from a mixture of LMF and ethanol, resulting in 5.7 g of 8-chloro-1-ethyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid in the form of colorless needles m.p. 215-217 S. .. 7 Found, I: C 50.40; And 2.72; N 4.93. C, 2 8 h2C.8 C 50.11; H 2.80; Calculated N 4.87. The starting compound, 8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester, was prepared as follows. 2-Chloro-3,4-difluoroaniline (9.6 g) and ethoxymethylenemalonic acid diethyl ester (12.8 g) are mixed and heated for 2 hours at 120-130 C. After cooling, the mixture is added to diphenyl ether ( 100 f-tn) and boil for 30 minutes. The reaction mixture is cooled, washed with benzene and dried. The residue is recrystallized from DMF, resulting in 13.3 g of 8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester as a colorless powder, mp. 292-293 ° C (decomposition). Example 8. 8-chloro-1-ethyl-6-fluoro-1, 4-dihydro-4-oxo-7- (1-piperazinyl) quinoline 3-carboxylic acid hydrochloride. A mixture of 8-chloro-1-ethyl-6,7-difluoro-1, 4-dihydro-4-oxoquinoline-3-carbonic acid (0, b5 g), piperazine (1.0 g) and pyridine (5 ml) kip t for 30 min. The reaction mixture was evaporated and acidified with hydrochloric acid. The precipitated precipitate is collected and recrystallized from a mixture of water and ethanol, resulting in a yield of 0.60 g of 8-chloro-1-ethyl-6-fluoro-1, 4-dihydro-4 oxo-7- (1-piperazinyl) -quinoline hydrochloride -3-carboxylic acid in the form of a colorless powder, so pl. . Found,%: C 49.30; H 4.59} N 10.25. C H OjNjFCl-MCl 1 / 4С2Н OH. Calculated,%: C 49.33; And 4.89; N 10.46. Example 9. 8-Chloro-1-ethyl-b-fluoro-1, 4-dihydro-4-oxo-7 (1-piperazinyl) quinoline-3-carboxylic acid {P, 25 g), sodium formate (0.5 d) 87% formic acid (5 ml) and 37 h formaldehyde solution (5 ml are mixed and boiled for 6.5 h. The solution is evaporated and basified with an aqueous solution of sodium hydroxide. The solution is neutralized with acetic acid and extracted dichloromethane and evaporated. The residue is recrystallized from ethanol to give 0.21 g of 8-chloro-1-ethyl-6-0tor-1, -dihydro-oxo-7-M methyl-1-piperazinyl) -quinoline-3 carboxylic acids s in the form of a colorless powder, so pl. 213-216 ° C.
    Found,%: C 5.98; H 5.20; N 11.1.
     J) 3N, FCM / fH20.
    Calculated,%: C, 8ij; .H, 5.28; N 11.29.
    Example 10. 1-Ethyl-6,8-difluoro-1, -dihydro-7- (methyl-1-piperazinyl) -oxoquinoline-3 carboxylic acid.
    A mixture of 1.35 g of 1-ethyl-6,7,8-trifluoro-1, -dihydro 4-oxoquinoline-3 carboxylic acid, 2.5 rN -methylpiperazine i of pyridine. The mixture is boiled under reflux for 2 hours. The mixture is evaporated to dryness, neutralized with aqueous acetic acid and extracted with dichloromethane. The organic layer is dried over anhydrous sodium sulfate and evaporated. The residue is recrystallized from a mixture of dimethylformamide and ethanol to obtain 1.5 g of (86) 1-ETHYL-6, 8-di L-1-1, 4-dihydro 7- (-methyl-1-piperazinyl) -oxoxin-3-carboxylic acid in the form of colorless crystals, tp, 2A221 ° C.
    Found,%: C 57, H 5.9; N 11.83.
    OPN
    Calculated,%: C 58.11; H 5, N 11.96.
    Experiment 1. The antibacterial effect of the compounds obtained according to the present invention was evaluated using the standard agar dilution method against gram ples (Teln and gram negative bacteria. The results obtained in comparison with the data for the known compounds are shown in Table 1. The compounds of examples 2, 3, 5i 6 , 8 and 9 more
    than nalidixin (MM) and pipemidinovy acids (PPA) against gram-positive and gram-negative bacteria.
    Experiment 2, The antibacterial effect of the compounds of examples 2, 3 and 6 was determined by the method of systemic infections. The test results are presented in Table. 2 in comparison with the data for LM-71i, nalidixic (NA), pimemidinic acids (PPA) and miloxacin, (M1X). Systemic infections were carried out on mouse male with a weight of 20) by the intraperitoneal method, using suspensions of the following test strains; mov in 0.5 ml extract of the central part of the strain containing 5% mucin: Pseudonranas aeruginpsa 6N11187, .3.3 x X 10 cells, Settatla. marcescens 6N7377 2.2 X 10 cells and Stapbylococcus aureiis Smith 3.0 x 10 cells. The drugs are administered to the mice orally twice a day: immediately after and after f hours after infection. The therapeutic effect of drugs is estimated by survival. Comparison of the antibacterial action in vivo is carried out on the basis of the average effective dose (ED) calculated from the sample-analysis data. The antibacterial action .In vivo of compounds of examples 2, 3 and 6 is significantly greater than the activity of compounds AM-715, NA, PPA and miloxacin against systemic infections of mice with each type of bacteria.
    In tab. 2 shows the comparative results of the action of the compounds of examples 2, 3 and 6, AM-715, NA, PPA and M2X against systemic infections (AN-715: 1-methyl-6-fluoro-1, -dihydro-7- (1-piperazinyl) -A-oxoquinolin-3-carboxylic acid; NA — nalidixin-in-acid; PPA (pimemidic acid).
    Table 1
    BacIHus subttUs PC1219 O.Y. 0.20 0.10 Staphytococcus aureus 209P 0.39 0.39 0.78 0.10 0.20 0.20 6.25 6.25-0, 20 0.78 0.78 100 25
    11 Minimal Inga Organism ililll 1.56 0.783.13 S. aureus LTCC1 775 Escfierichla coli HIHJ. 0.05 0.050.025 E. coli ATCC10536 0.05 0.050.05 Proteus vulgaris 3167 0.025 0.050.025 P. vulgnris XK Denken 0.05 0.100.20 Klebsiella pneumoniae IFO 3512 0.025 0.025 0.025 Pseudomonas aeruginosa Vl 0.39 1.56 6.25 P .eruginosa fF012689 0.78 3.13 6.25 P. aeruqiriosa 11D1210 3.13 12.5 P. aerugtnosa 11D1130 0.78 3.13 Salmonella enterltidls 11D604 0.20 0.39 0.39 Shigella sonnet .11D969 0.05 0 , 05 0.05
    Serratia (Tiarcescens 1106.8 0.10 0.20
    0,200,39
    0,100,20
    0,100,20 0,39 0,39 0,20
    0.780.20 0.78 0.20 0.39
    dls
    0.780.78 1.56 0.39 1.56
    3,136.25
    12,512,5
    6,256,25
    6,256,25
    s
    3,136.25
    978727
    12
    Continued table. 1 Connection
    0.39 0, -39 1.56
    100 100 100 100
    100 100 100 Test concentration, mg / ml as per example llll 0,391,56 1,56,100,100 0,106,05 0,653,131,56 0,053,131,56 0,050,05 0,053,13З, 13 0,050,05 0,393,136,25 0,200,10 1,561,56 0,025 0 , 05 0.05 3.13 1.56 6.25 10012.5 6.25 3.13 12.5 20025 20050 20025 1.56, 12.512.5 1.561.56 0.05
    13 where or in general
    978727
    U Table 2 H - ethyl; R 2 Na - piperazinyl,, -methyl-1-pipa.-at boiling, with the release of the target razinil; 0 product in free form or. In R-fluorine, chlorine or R4, KOTO-form salt. Sources of Information, a six-membered ring taken into account in the examination of their salts, are different. 1. Elderfield R-Heterocyclic that conducts the reaction of compound 45, T. 6, M., Foreign Formula Literature, 1980, p. . 30 where R, Rj and R4 are defined above; X is fluorine; with piperazine of the general formula - 35R where R5 is hydrogen or methyl, in the medium of an organic solvent.
    权利要求:
    Claims (1)
    [1]
    Formula of the invention ; The method for producing derivatives of chiolinincarbric acid of the common morgue forde “2 R 3 SOON
    - ethyl;
    - fluorine;
    piperazinyl, 4 ~ methyl-1-piperazinyl; 40
    -`` fluorine, chlorine or R'H R4, which together can close the six-membered ring, salts, about t, or by the fact that they carry out the general formula a different reaction of compound 45
    0 -J-L / Cooh χ I r 4I R 1 where R 1 , R 2 and R 4 are as defined above; X is fluorine; with piperazine total formulas
    r 5 - 5 W where R ^ is hydrogen or methyl, in an organic solvent, when boiled, with the isolation of the target product in free form or in the form of salt.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU978727A3|1982-11-30|Process for producing quinoline carbohylic acid derivatives or salts threreof
    US4292317A|1981-09-29|1,4-Dihydro-quinoline-3-carboxylic acid derivatives, process for their preparation and compositions containing them
    SU1588281A3|1990-08-23|Method of producing derivative of quinoline or its pharmaceutically acceptable ester, or their salts
    EP0167763B1|1988-08-03|7-amino-1-cyclopropyl-6,8-dihalo-1,4-dihydro-4-oxo-3-quinoline-carboxylic acids, process for their preparation and bactericidal agents containing them
    KR870001016B1|1987-05-23|Process for preparing 6-fluoro-1,4-dihydro-4-oxo-7-substituted piperazinylquinoline-3-carboxylic acid derivatives
    EP0169993B1|1988-12-28|7-| and 7-| 3-quinoline carboxylic acids
    DK153552B|1988-07-25|ANALOGY PROCEDURE FOR PREPARING 1,8-NAPHTHYRIDE INGREDIATES
    US4499091A|1985-02-12|1-Amino |-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
    HU199821B|1990-03-28|Process for production of derivatives of in 8 position substituated quinoline carbonic acid and medical compositions containing them
    US3300499A|1967-01-24|4-alkyl |-1, 4-dihydro-1-oxobenzo [f] [1, 7] naphthyridine 2-carboxylic acid derivatives
    PT89352B|1993-09-30|7- | -1,4-DIHYDRO-4-OXOQUINOLEINE-3-CARBOXYLIC ACID AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    EP0109284B1|1989-01-11|6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo|quinolizine-2-carboxylic acid and derivatives
    HU195954B|1988-08-29|Process for producing 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid ester derivatives and pharmaceutics comprising the same
    DE3517535A1|1986-11-20|1-ARYL-4-CHINOLON-3-CARBONIC ACIDS
    US4472406A|1984-09-18|Antimicrobial 6,7-dihydro-8-|-5-methyl-1-oxo-1H,5H-benzo [ij]quinolizine-2-carboxylic acids and derivatives
    US3917609A|1975-11-04|Pyrroloquinoline carboxylic acids and derivatives
    IE61624B1|1994-11-16|Tricyclic compounds
    US4971970A|1990-11-20|Benzoheterocyclic compounds
    US4720495A|1988-01-19|Benzo[ij]quinolizine-2-carboxylic acids useful for treating bacterial infection
    US4348521A|1982-09-07|Substituted pyridoquinoxaline-6-carboxylic acids and derivatives thereof
    SU1029829A3|1983-07-15|Process for preparing derivatives of 1,8-naphthiridine or their pharmaceutically acceptable salts
    US4499270A|1985-02-12|Substituted pyridoquinoxaline-6-carboxylic acids and derivatives thereof
    JP2666320B2|1997-10-22|Antibacterial compound
    KR920006780B1|1992-08-17|Quinolnone carboxcylic acid derivatives
    US4585868A|1986-04-29|Precursors of 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid
    同族专利:
    公开号 | 公开日
    ES494352A0|1981-04-16|
    SG71386G|1987-03-27|
    CA1159454A|1983-12-27|
    DE3031767C2|1994-04-14|
    IT8024111D0|1980-08-11|
    AU6112280A|1981-02-26|
    DE3031767C3|1994-04-14|
    FR2463771A1|1981-02-27|
    GB2057440B|1983-10-12|
    BE887574R|1981-06-15|
    MY8700155A|1987-12-31|
    HK98486A|1986-12-24|
    CH645641A5|1984-10-15|
    HU184817B|1984-10-29|
    DE3031767A1|1981-03-26|
    ES8104233A1|1981-04-16|
    BE884824A|1980-12-16|
    IT1132392B|1986-07-02|
    SE8005534L|1981-02-23|
    JPS5630964A|1981-03-28|
    AU533141B2|1983-11-03|
    SE440353B|1985-07-29|
    SU1015827A3|1983-04-30|
    FR2463771B1|1983-04-22|
    GB2057440A|1981-04-01|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    RU2514937C2|2008-08-06|2014-05-10|Байомарин Фармасьютикалз Инк.|Dihydropyridophthalazinone inhibitors of polypolymerase|CA947301A|1970-01-28|1974-05-14|Sumitomo Chemical Company|Process for the preparation of compound having antibacterial action|
    BE793524A|1971-12-30|1973-06-29|Riker Laboratories Inc|BENZOQUINOLIZINE-CARBOXYLIC ACIDS AND THEIR DERIVATIVES|
    US4156726A|1974-12-07|1979-05-29|Fisons Limited|4-Oxo-2-carboxyl quinoline derivatives used as antiallergic compounds|
    JPS5534144B2|1977-05-16|1980-09-04|
    JPS54112877A|1978-02-20|1979-09-04|Sumitomo Chem Co Ltd|Preparation of 1-substituted-1,4-dihydro-4-oxo-3-pyridine carboxylic acid derivatives|
    DE2953974C2|1978-04-12|1992-06-25|Otsuka Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp|
    AU553415B2|1983-09-19|1986-07-17|Abbott Japan Co., Ltd.|6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids|US4416884A|1978-04-12|1983-11-22|Otsuka Pharmaceutical Co., Ltd.|Piperazinylbenzoheterocyclic compounds|
    NO156828C|1980-11-10|1987-12-02|Otsuka Pharma Co Ltd|ANALOGY PROCEDURE FOR THE PREPARATION OF ANTIBACTERYLY EFFECTIVE BENZOHETEROCYCLIC COMPOUNDS.|
    SE440354B|1981-02-19|1985-07-29|Kyorin Seiyaku Kk|quinolinecarboxylic|
    JPH0222074B2|1981-04-24|1990-05-17|Otsuka Pharma Co Ltd|
    JPH0312061B2|1981-12-15|1991-02-19|Nippon Shinyaku Co Ltd|
    US4472405A|1982-11-12|1984-09-18|Riker Laboratories, Inc.|Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzoquinolizine-2-carboxylic acid and derivatives|
    US4472406A|1982-11-12|1984-09-18|Riker Laboratories, Inc.|Antimicrobial 6,7-dihydro-8--5-methyl-1-oxo-1H,5H-benzo [ij]quinolizine-2-carboxylic acids and derivatives|
    JPS59128383A|1982-12-29|1984-07-24|Kanebo Ltd|Novel quinolinecarboxylic acid derivative and antibacterial agent containing said compound as active component|
    JPH0412268B2|1983-02-22|1992-03-04|Kyorin Seiyaku Kk|
    DE3308908A1|1983-03-12|1984-09-13|Bayer Ag, 5090 Leverkusen|BACTERICIDAL AGENTS|
    DE3318145A1|1983-05-18|1984-11-22|Bayer Ag, 5090 Leverkusen|7-AMINO-1-CYCLOPROPYL-6,8-DIFLUOR-1,4-DIHYDRO-4-OXO-3-CHINOLINE CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR CONTAINING ANTIBACTERIAL AGENTS|
    JPH0227639Y2|1983-06-13|1990-07-25|
    AU553415B2|1983-09-19|1986-07-17|Abbott Japan Co., Ltd.|6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids|
    US4571396A|1984-04-16|1986-02-18|Warner-Lambert Company|Antibacterial agents|
    GB8412094D0|1984-05-11|1984-06-20|Scras|Quinoline derivatives|
    DE3420743A1|1984-06-04|1985-12-05|Bayer Ag, 5090 Leverkusen|7-AMINO-1-CYCLOPROPYL-6,8-DIHALOGEN-1,4-DIHYDRO-4-OXO-3-CHINOLINE CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR CONTAINING ANTIBACTERIAL AGENTS|
    US5468861A|1984-06-04|1995-11-21|Bayer Aktiengesellschaft|8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and alkyl esters thereof|
    US4550104A|1984-07-20|1985-10-29|Warner-Lambert Company|Antibacterial thiazolo-quinolines and thiazolo-naphthyridines|
    US4550103A|1984-07-20|1985-10-29|Warner-Lambert Company|Antibacterial 1-oxo-benzoquinolizine-2-carboxylic acids|
    ZA859283B|1984-12-06|1987-07-29|Pfizer|Substituted dihydroquinolone carboxylic acids and anti-bacterial compositions containing them|
    JPH056543B2|1984-12-17|1993-01-26|Kyorin Seiyaku Kk|
    JPS61143364A|1984-12-17|1986-07-01|Kyorin Pharmaceut Co Ltd|Production of quinolonecarboxylic acid derivative|
    HUT40639A|1985-03-08|1987-01-28|Kyorin Seiyaku Kk|Process for producing quinolon-carboxylic acid derivative and pharmaceutical composition containing them|
    JPS61205258A|1985-03-08|1986-09-11|Kyorin Pharmaceut Co Ltd|Quinolonecarboxylic acid derivative and production thereof|
    EP0195135B1|1985-03-21|1992-06-17|Kyorin Seiyaku Kabushiki Kaisha|A process for the preparation of quinoline carboxylic acid derivatives|
    GB8512143D0|1985-05-14|1985-06-19|Beecham Group Plc|Method of treatment|
    US4686221A|1985-10-01|1987-08-11|Kanebo, Ltd.|Quinolinecarboxylic acid compounds and antimicrobial agent containing the same|
    JPS61118370A|1985-10-30|1986-06-05|Kyorin Pharmaceut Co Ltd|Quinolonecarboxylic acid and its preparation|
    JPS62228063A|1985-12-27|1987-10-06|Sankyo Co Ltd|Quinolinecarboxylic acid derivative|
    DE3705621C2|1986-02-25|1997-01-09|Otsuka Pharma Co Ltd|Heterocyclic substituted quinolonecarboxylic acid derivatives|
    JPH0753715B2|1986-02-25|1995-06-07|大塚製薬株式会社|Benzoheterocyclic compound|
    JPS62205060A|1986-03-04|1987-09-09|Kyorin Pharmaceut Co Ltd|8-substituted quinolonecarboxylic acid derivative|
    JPS62215572A|1986-03-17|1987-09-22|Kyorin Pharmaceut Co Ltd|Quinolone carboxylic acid derivative|
    ZA874696B|1986-07-03|1988-01-04|F. Hoffmann-La Roche & Co. Aktiengesellschaft|Acyl derivatives|
    US5591744A|1987-04-16|1997-01-07|Otsuka Pharmaceutical Company, Limited|Benzoheterocyclic compounds|
    US4851418A|1987-08-21|1989-07-25|Warner-Lambert Company|Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent|
    JPS6483068A|1987-09-25|1989-03-28|Otsuka Pharma Co Ltd|Production of benzo-heterocyclic compound|
    JPH01175936A|1987-12-28|1989-07-12|Kyorin Pharmaceut Co Ltd|Tablet containing 6,8-difluoro-1--1,4-dihydro-7-4-methyl-1-pi-perazinyl)-4-oxo-3-quinolinecarboxylic acid as active component|
    EP0486687A4|1989-07-21|1992-06-17|Iolab Corporation|Quinolonecarboxylic acid derivatives|
    JP2526128B2|1988-08-08|1996-08-21|エスエス製薬株式会社|Quinolonecarboxylic acid derivative|
    US5185337A|1989-03-29|1993-02-09|Otsuka Pharmaceutical Co., Ltd.|Pyrroloquinoline derivatives and pharmaceutical compositions for antimicrobial use|
    FR2655545B1|1989-12-11|1994-06-10|Rhone Poulenc Sante|NEW THERAPEUTIC APPLICATION OF FLUOROQUINOLONE DERIVATIVES.|
    FR2656611B1|1990-01-04|1992-05-07|Hoechst France|NEW QUINOLONES, THEIR SALTS, USEFUL AS ANTIMICROBIAL AGENTS, PREPARATION METHOD AND THEIR APPLICATION AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM.|
    FR2673426B1|1991-03-01|1993-07-16|Bouchara Sa|NEW QUINOLONES, THEIR PREPARATION PROCESS AND THE CLOSING COMPOSITIONS.|
    FR2675144B1|1991-04-10|1995-06-16|Bouchara Sa|NEW DIFLUORINATED QUINOLONES - THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.|
    US5532239A|1993-08-02|1996-07-02|Assistance Publique - Hopitaux De Paris|Therapeutic application of fluoroquinolone derivatives|
    AT223901T|1994-03-01|2002-09-15|Ishihara Sangyo Kaisha|METHOD FOR PRODUCING 5,7 DICHLOR-4-HYDROXYCHINOLINE|
    SE9904108D0|1999-11-15|1999-11-15|New Pharma Research Ab|New compounds|
    US7973022B2|2006-02-17|2011-07-05|Idexx Laboratories, Inc.|Fluoroquinolone carboxylic acid salt compositions|
    US20070197548A1|2006-02-17|2007-08-23|Murthy Yerramilli V S|Fluoroquinolone compositions|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    JP10677679A|JPS5630964A|1979-08-22|1979-08-22|Novel substituted quinolinecarboxylic acid and its preparation|
    BE2/58706A|BE884824A|1979-08-22|1980-08-19|QUINOLEINE-CARBOXYLIC ACID DERIVATIVES AND PROCESS FOR THEIR PREPARATION|
    BE2059018|1981-02-19|
    [返回顶部]